| Literature DB >> 29346778 |
Brad A Friedman1, Karpagam Srinivasan2, Gai Ayalon2, William J Meilandt2, Han Lin2, Melanie A Huntley3, Yi Cao3, Seung-Hye Lee2, Patrick C G Haddick4, Hai Ngu5, Zora Modrusan6, Jessica L Larson3, Joshua S Kaminker7, Marcel P van der Brug4, David V Hansen8.
Abstract
Microglia, the CNS-resident immune cells, play important roles in disease, but the spectrum of their possible activation states is not well understood. We derived co-regulated gene modules from transcriptional profiles of CNS myeloid cells of diverse mouse models, including new tauopathy model datasets. Using these modules to interpret single-cell data from an Alzheimer's disease (AD) model, we identified microglial subsets-distinct from previously reported "disease-associated microglia"-expressing interferon-related or proliferation modules. We then analyzed whole-tissue RNA profiles from human neurodegenerative diseases, including a new AD dataset. Correcting for altered cellular composition of AD tissue, we observed elevated expression of the neurodegeneration-related modules, but also modules not implicated using expression profiles from mouse models alone. We provide a searchable, interactive database for exploring gene expression in all these datasets (http://research-pub.gene.com/BrainMyeloidLandscape). Understanding the dimensions of CNS myeloid cell activation in human disease may reveal opportunities for therapeutic intervention.Entities:
Keywords: Alzheimer’s disease; FACS; RNA-seq; gene expression; microglia; microgliosis; myeloid; neurodegeneration; neuroinflammation; tauopathy
Mesh:
Year: 2018 PMID: 29346778 DOI: 10.1016/j.celrep.2017.12.066
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423